Health-care companies fell slightly amid mixed earnings prospects.
Taiwan's leading eye-care companies such as Universal Vision Biotechnology and Pegavision are likely to emerge as major beneficiaries of China's reopening, said analysts at brokerage Citi.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
01-17-23 1659ET